second dose of meningococcal conjugate vaccine (Menactra, Menveo)

April 2011

Please see new information concerning the use of Menactra

More teens will get a second dose of meningococcal conjugate vaccine (Menactra, Menveo)...due to CDC's latest recommendations.

One dose is usually given at age 11 or 12. Now a second dose is recommended at age 16...because protection only lasts about 5 years.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

PPIs more reasons to limit the use of PPIs
Supplements potassium iodide for radiation exposure
Hypertension another angiotensin receptor blocker for hypertension called azilsartan (Edarbi, eh-DAR-bee)
Infectious Diseases avoid quinolones for UNCOMPLICATED urinary tract infections (UTIs) in women
Vaccines second dose of meningococcal conjugate vaccine (Menactra, Menveo)
Women's Health questions about drug safety in pregnancy
Respiratory & Allergy whether patients on stimulants for ADHD can take cough, cold, and allergy meds containing decongestants
Benzodiazepines how to use benzodiazepines appropriately
Anticoagulants how long to continue warfarin after a venous thromboembolism (VTE)
STIs new drug options and doses for treating sexually transmitted diseases (STDs) in CDC's new guidelines
Oral Health which patients should get antibiotics before dental work
Heart Disease whether more women should get a statin to prevent cardiovascular disease